Stock comparison
Enovis
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ENOV
Enovis
Market cap
$1.4B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$20.85B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ENOV | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 18F | 60C | MTD |
| Benjamin Graham | 18F | 33F | MTD |
| Philip Fisher | 27F | 54C | MTD |
| Peter Lynch | 30F | 52C | MTD |
| Joel Greenblatt | 0F | 58C | MTD |
| Charlie Munger | 24F | 63C | MTD |
| Terry Smith | 20F | 62C | MTD |
Side-by-side metrics
| Metric | ENOV | MTD |
|---|---|---|
| Market cap | $1.4B | $20.85B |
| P/E (TTM) | - | 23.9x |
| EV/EBIT | - | 20.6x |
| ROIC (TTM) | 1.87% | 36.09% |
| Gross margin | 56.81% | 57.79% |
| Net margin | -49.91% | 21.4% |
| Revenue CAGR 5y | 12.05% | 2.01% |
| EPS CAGR 5y | - | 6.12% |
| Debt / Equity | 1.0x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ENOV leads on
- EV/EBIT-vs 20.6x+114%
- P/E (TTM)-vs 23.9x+105%
- Revenue CAGR 5y12.05%vs 2.01%+83%
MTD leads on
- Net margin21.4%vs -49.91%+143%
- Debt / Equity-vs 1.0x+102%
- ROIC (TTM)36.09%vs 1.87%+95%
- Market cap$20.85Bvs $1.4B+93%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.